• RotaChrom CPC Instruments & Solutions
  • Technology
  • About Us
  • FAQ
  • Blog
  • Webinars
  • Podcasts
  • Pressroom
  • Contact
Here you can see the logo of RotaChrom Technologies.
Here you can see the logo of RotaChrom Technologies.
  • Products
    • CPC Modeler
    • GMP rCPC
    • rCPC
    • iCPC
    • Continuous CPC
    • pCPC
    • SKIDS
  • Pricing
  • Technology
  • Applications
    • Pharma and biotech
    • Cosmetics and Fragrances
    • Food and Beverages
    • Botanical applications
  • Calculator
  • Company
    • About Us
    • Events
  • Resources
    • Blog
    • Webinars
    • Publications
    • Pressroom
    • FAQ
    • Podcasts
  • Contact
    • Career
    • Contact
    • Book a meeting

Enhancing API Manufacturing with Contract Development and Manufacturing Organizations (CDMOs) and Industrial-Scale Centrifugal Partition Chromatography (CPC)

May 15, 2024
In Education, News
Share via Share via Share via Share via

The manufacturing of small molecule Active Pharmaceutical Ingredients (APIs) is a multifaceted process requiring specialized facilities, regulatory expertise, and scientific acumen. To navigate this complex landscape, pharmaceutical innovators often collaborate with Contract Development and Manufacturing Organizations (CDMOs). Among the myriad techniques for producing high-purity pharmaceutical products, preparative chromatography stands out as a reliable method for separating, purifying, and isolating substances from intricate mixtures. This article explores the pivotal role of APIs, the significance of CDMOs, and the groundbreaking approach offered by RotaChrom in API manufacturing through Industrial-Scale Centrifugal Partition Chromatography (CPC).

API Manufacturing: A Complex Endeavor

Active Pharmaceutical Ingredients (APIs) are the core biologically active components in medicinal products, driving the desired therapeutic effects. APIs can be derived from diverse sources and produced through various methods, including chemical synthesis and fermentation. The stringent regulation of API production underscores its critical role in ensuring the safety and efficacy of final medicinal products. Factors such as quality control, yield, cost, and scalability further contribute to the complexity of API manufacturing.

The Role of CDMOs

Contract Development and Manufacturing Organizations (CDMOs) play a pivotal role in the pharmaceutical landscape by offering a spectrum of services, including research and development, process optimization, analytical testing, quality control, regulatory affairs, and manufacturing. Pharmaceutical companies leverage CDMOs to access expertise and resources they may lack internally or to outsource specific aspects of the development and manufacturing process. CDMOs guide companies through the entire development process, from early-stage research to commercial manufacturing.

Revolutionizing API Purification with RotaChrom’s CPC

RotaChrom introduces a groundbreaking method for preparative purification: Industrial-Scale Centrifugal Partition Chromatography (CPC). Unlike traditional methods relying on solid stationary phases, RotaChrom’s technology adopts a liquid-liquid approach for precise molecular separation. The system boasts superior yield and purity, reduces costs, and simplifies downstream method development for diverse purification tasks.

Key Features of RotaChrom’s CPC Technology

Elimination of Silica Gel Dependency: RotaChrom’s CPC technology operates without the need for silica gel, a departure from traditional methods.

  • Liquid-Liquid Chromatography (LLC) Principles: Integrating liquid-liquid separation with chromatography, the system utilizes two immiscible liquid phases.
  • High Sample Volume Loading: The strong centrifugal force ensures solutes can access the entire volume of the liquid stationary phase, allowing high sample volumes.
  • Complete Sample Recovery: Liquid-liquid chromatography eliminates the issue of irreversible adsorption, enabling complete sample recovery.
  • Wide Application Spectrum: RotaChrom’s CPC system adapts seamlessly to various applications, spanning pharmaceuticals, food and beverage, natural extracts, cosmetics, and fragrances.
  • Expanded product portfolio from the benchtop device through pilot-scale to continuous manufacturing and industrial-scale instruments.

Conclusion

In the dynamic landscape of API manufacturing, RotaChrom’s Liquid-Liquid Chromatography approach represents a paradigm shift. By replacing traditional solid stationary phases with a liquid-liquid system, this innovative technology not only enhances precision in molecular separation but also addresses challenges related to yield, purity, and downstream development. As the pharmaceutical industry seeks more efficient and cost-effective solutions, RotaChrom’s CPC system emerges as a powerful tool, revolutionizing the purification process across diverse applications.

Previous article
Centrifugal Partition Chromatography (CPC): A Sustainable Approach for Complex Mixture Separation
Next article
Optimizing Solvent Consumption for Your Chromatographic Solution

Related News

Other posts that you should not miss.
Header to SelectScience interview post

The Secret to Better Analysis: Centrifugal Partition Chromatography

February 2, 2023
-
Education, Interviews, News
Centrifugal partition chromatography is a powerful yet underutilized separation technique that can save costs and increase scalability in your lab. Despite the popularity of HPLC-based methods, these techniques…
Read More →
3 MIN READ
Andras Gaspar talking to Bence Mihaly

The pCPC – Interview with Andras Gaspar, PhD, RotaChrom’s Chief Product Officer

June 22, 2022
-
News
Versatile and robust – This is the pCPC RotaChrom’s pCPC is the largest and most versatile platform in the company’s product portfolio. It can be used for many…
Read More →
5 MIN READ

Revolutionizing Complex Mixture Purification with Industrial-Scale Centrifugal Partition Chromatography (CPC)

August 23, 2024
-
Education, News
The manufacturing and purification of small molecule Active Pharmaceutical Ingredients (APIs) is a multifaceted process requiring specialized facilities, regulatory expertise, and scientific acumen. To navigate this complex landscape,…
Read More →
3 MIN READ

Latest News

Advancing Separation Science: CPC Device Installation and Its Impact

April 17, 2025 – News

RotaChrom at Flow Chemistry Europe 2025: Exploring Innovation Through CPC Technology

April 16, 2025 – Events, News

SZTE’s Award-Winning Innovation: A Natural Breakthrough in Obesity Prevention

February 4, 2025 – Education, News, Studies

Innovations in Chiral Purification: Exploring Techniques and Future Potential

January 31, 2025 – Download, Education, News

Webinars

Separation of Remdesivir Diastereomeres by Centrifugal Partition Chromatography

September 25, 2023

Green Features of Centrifugal Partition Chromatography

May 10, 2021

Contact Us

RotaChrom Technologies PLC (Headquarters)

Csillag street 2/A, Kecskemet, HU-6000

+36 70 885 6922

RotaChrom North America Inc.

300 Spectrum Center Drive, Irvine, CA 92618

+1 (720) 220-5669

Cookie Policy  /  Data Protection Policy  /  RotaChrom® is a registered trademark of Rotachrom Technologies in the USA and EU. / © 2025 RotaChrom Technologies. All rights reserved.
Enhancing API Manufacturing with Contract Development and Manufacturing Organizations (CDMOs) and Industrial-Scale Centrifugal Partition Chromatography (CPC) - Rotachrom Technologies